Perry Gordon
Impact in
-
- Protease and Inhibitor Mechanisms
-
- Cell Adhesion Molecules Research
Papers in
-
- Bone Metabolism and Diseases 3
- Natural product bioactivities and synthesis 2
- Biochemical and Structural Characterization 1
- ATP Synthase and ATPases Research 1
-
- Protease and Inhibitor Mechanisms 4
- Co-authors
- S. Cyrus Khojasteh (1 shared paper)Kevin R. Holme (1 shared paper)Kyoung‐Jin Lee (1 shared paper)Patrick J. Sinko (1 shared paper)Yong‐Hee Lee (1 shared paper)Tove Tuntland (5 shared papers)Jonathan Chang (5 shared papers)Arnab K. Chatterjee (5 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (6 papers)Pharmaceutical Research (1 paper)Drug Metabolism Reviews (1 paper)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesSouth KoreaUnited Kingdom
In The Last Decade
Perry Gordon
9 papers receiving 271 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 54
- Immunology and Allergy 16
- Toxicology 8
- Oncology 61
- Organic Chemistry 63
Countries citing papers authored by Perry Gordon
This map shows the geographic impact of Perry Gordon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Perry Gordon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Perry Gordon more than expected).
Fields of papers citing papers by Perry Gordon
This network shows the impact of papers produced by Perry Gordon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Perry Gordon. The network helps show where Perry Gordon may publish in the future.
Co-authors
The 25 scholars most cited alongside Perry Gordon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 102 | |
| 2 | 2004 | 32 | |
| 3 | 2006 | 26 | |
| 4 | 2019 | 25 | |
| 5 | 2014 | 25 | |
| 6 | 2008 | 24 | |
| 7 | 2006 | 21 | |
| 8 | 2006 | 14 | |
| 9 | 2007 | 11 |
About Perry Gordon
Perry Gordon is a scholar working on Molecular Biology, Cancer Research, Oncology, Cell Biology and Pharmacology, having authored 9 papers that have together received 280 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (4 papers), Bone Metabolism and Diseases (3 papers), Natural product bioactivities and synthesis (2 papers), Analytical Methods in Pharmaceuticals (1 paper), Bone health and treatments (1 paper), Biochemical and Structural Characterization (1 paper), Pneumocystis jirovecii pneumonia detection and treatment (1 paper) and ATP Synthase and ATPases Research (1 paper). The work is most often cited by research in Cancer Research (54 citations), Immunology and Allergy (16 citations), Toxicology (8 citations), Oncology (61 citations) and Organic Chemistry (63 citations). Perry Gordon has collaborated with scholars based in United States, South Korea and United Kingdom. Frequent co-authors include S. Cyrus Khojasteh, Kevin R. Holme, Kyoung‐Jin Lee, Patrick J. Sinko, Yong‐Hee Lee, Tove Tuntland, Jonathan Chang, Arnab K. Chatterjee, Donald S. Karanewsky and Michael J. Roberts. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Pharmaceutical Research, Drug Metabolism Reviews and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.